Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
about
Use of thiopurines in inflammatory bowel diseaseUse of thiopurines in inflammatory bowel disease: Safety issues.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry.Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease.Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties.MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.The role of thiopurine metabolite monitoring in inflammatory bowel disease.Common GI Drug Interactions in the Elderly.Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Thiopurine metabolite testing in inflammatory bowel disease.Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.Risk factors for thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype.Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly.Monitoring thiopurine metabolites in inflammatory bowel disease.Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease.Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
P2860
Q26824662-1BF5DC19-52E3-4D6B-9B76-7606E227A227Q33621267-E3A5FB3D-7C73-4FC9-BC42-15F1890E872CQ33654733-A05D9B40-B260-4714-9E5E-E94A45E18723Q35221802-C6494F27-1E40-47A8-99A8-8B1554CC9DD8Q37019489-A846C85B-EFAC-4BE9-8896-C2688D7073C5Q37620338-F3718E5B-F949-4F73-841D-7F0B5F71E827Q37703514-733C63BB-C8E3-403E-A9B6-23AC60F61A12Q37833064-5AE12BBE-A238-4BEA-BC35-DC449DB4E1AFQ38179509-3B0E5D7F-950D-4BA5-819E-41E3E15546F5Q38195146-611512F7-DBB9-4019-9D6B-B9B1B479777AQ38200692-5F3351A5-0983-46A3-ACB7-8411833CF3B5Q38230328-0C5CCDC5-842F-484E-88BB-398DF3F0174BQ38253469-4DD164FA-8F44-4FE3-BCD3-40C7954FC4E1Q38563075-95020363-765F-4430-BDC9-754C2868A544Q38618602-B38603AD-75BB-4E70-AC8B-DFECE080ABD7Q38881833-A620D414-84FB-4E3B-803C-2239D84AC61DQ40044141-F6ADF772-83DC-498C-8853-B097BCAA6E38Q41169995-EDF34B90-BA19-4EFD-B694-18AB5A9692EEQ41642129-E8FCF50D-44A5-4610-B58B-0BE64CA9B2B1Q44316625-7F5FB2A6-D5AF-4748-8D10-9FC7D0FE4771Q47137978-4B6FAF9D-C976-442E-861C-3A14F5416B79Q50448602-17C4A11C-3849-4E6A-ABF0-F427520CF466Q50495588-AE018CD8-6F61-4A03-8520-BD2111A97AF8
P2860
Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@ast
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@en
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@nl
type
label
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@ast
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@en
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@nl
prefLabel
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@ast
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@en
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@nl
P2093
P2860
P1476
Influence of 5-aminosalicylic ...... der steady thiopurine therapy.
@en
P2093
A A van Bodegraven
A I Veldkamp
C J J Mulder
N K H de Boer
P M Hooymans
P de Graaf
P2860
P304
P356
10.1111/J.1476-5381.2010.00731.X
P407
P577
2010-07-01T00:00:00Z